Emerging risks | Growth Opportunities | APAC Insurance

Tuesday, November 3, 2026

Capital management, Home & Contents, Industry M&A, Motor, News, Non-life, Regulatory, Strategy

ACCC extends timeline for IAG’s RAC Insurance deal review following remedies

The regulator extended its review timeline for the US$946.3m deal by 15 business days to assess divestment remedies.

By

Gisella Lobo

November 3, 2026

•

2 min read

(Re)in AsiaSIRC 2026 Hub

(Re)in AsiaSIRC 2026HubExplore the hub →

Unlock this insight for free

Register for a free 14-day trial to read the full insight.

14 days of access to (Re)in Asia’s premium intelligence
Free daily briefing in your inbox each morning
No credit card required

Already have an account? Sign in →

(Re)in AsiaSIRC 2026 Hub

(Re)in AsiaSIRC 2026HubExplore the hub →

Read next

ACCC seeks feedback on IAG’s public benefit remedies offer for RAC deal October 20 2026
IAG, RAC challenge ACCC’s A$1.35bn deal block at tribunal October 8 2026
Second ACCC rejection sends IAG's RAC Insurance bid to public benefit test September 23 2026
IAG-RAC tribunal hearing set for March 2027, pending ACCC public benefit ruling October 12 2026
IAG offers to sell NRMA’s WA renewal rights in public benefit bid for RAC deal October 14 2026
IRDAI extends distribution reform feedback deadline to 31 October October 25 2026